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Summary
Syndecans are heparan sulfate proteoglycans that
modulate the activity of several growth factors and
cell adhesion molecules. PDZ domains in the adaptor
protein syntenin interact with syndecans and with the
phosphoinositide PIP2, which is involved in the regu-
lation of the actin cytoskeleton and membrane traf-
ficking. Here, we show that the syntenin PDZ domain-
PIP2 interaction controls Arf6-mediated syndecan
recycling through endosomal compartments. FGF re-
ceptor accompanies syndecan along the syntenin-
mediated recycling pathway, in a heparan sulfate- and
FGF-dependent manner. Syndecans that cannot recy-
cle via this pathway become trapped intracellularly
and inhibit cell spreading. This syntenin-mediated
syndecan recycling pathway may regulate the surface
availability of a number of cell adhesion and signal-
ing molecules.
Introduction
Syndecans are abundant type I membrane proteins that
bear heparan sulfate (HS) chains on their extracellular
domains. Via their HS chains, syndecans act as versa-
tile coreceptors, attracting and concentrating various
growth factors, morphogens, and adhesion molecules
at the cell surface and facilitating their interaction with
their specific receptors (Bernfield et al., 1999; Gallagher,
2001). The functions of the syndecans also depend on
their strongly conserved cytoplasmic domains that es-
tablish connections with signaling and cytoskeletal
molecules (Couchman, 2003) and with several PDZ pro-
teins, including syntenin (Grootjans et al., 1997).
PDZ proteins in general are implicated in the correct
organization and subcellular localization of receptors
and signal transduction components. As such, they are*Correspondence: pascale.zimmermann@med.kuleuven.be (P.Z.);
guido.david@med.kuleuven.be (G.D.)essential for the establishment and maintenance of cell
polarity and epithelial asymmetry, as well as for the de-
livery and concentration of receptors in the neuronal
synapse. PDZ domains are modules of 80–90 amino
acids that bind to short canonical peptide sequences,
most often the last 4–5 C-terminal amino acids of their
targets (Sheng and Sala, 2001). The PDZ domains of
syntenin interact with syndecans, but also with B-ephrins
(Lin et al., 1999) and glutamate receptors (Hirbec et al.,
2003). The physiological relevance of these interactions
is unknown. It has been suggested that syntenin regu-
lates protein transport in the early secretory pathway
(Fernandez-Larrea et al., 1999). Other studies identified
syntenin as a component of the apical early endocytic
compartment (Fialka et al., 1999) and also cell adhesion
sites (Zimmermann et al., 2001).
Recently, we showed that some PDZ domains also
interact with phosphoinositides (Zimmermann et al.,
2002), lipids that control membrane signaling and traf-
ficking (De Matteis and Godi, 2004). The syntenin PDZ
domains specifically bind phosphatidylinositol 4,5-bis-
phosphate (PIP2). Each of the two PDZ domains of syn-
tenin can engage either peptide (e.g., syndecan) or
PIP2. Yet, high-affinity binding requires both PDZ do-
mains in tandem, and the membrane-syntenin complex
with the highest stability consists of the PDZ1 domain
engaging PIP2 and the PDZ2 domain engaging synde-
can (Zimmermann et al., 2002).
Here, we investigated the relevance of the syntenin-
PIP2 interaction for the biology of the syndecans and
found that it is required for efficient exit of syndecan
from ADP-ribosylation factor 6 (Arf6) recycling endo-
somes. Cargo for the HS of syndecan, such as the FGF-
FGF receptor complex, accompanies syndecan along
the syntenin recycling pathway. Syndecans defective
for PDZ interaction or syntenin loss-of-function impair
cell spreading. We propose that the link made here be-
tween syndecan, HS ligands, syntenin, PIP2, and Arf6-
dependent membrane recycling identifies one piece of
the molecular framework by which syndecans control
cell surface dynamics and behavior.
Results
Impairing Syntenin-PIP2 Binding Results
in Perinuclear Accumulation of Syndecan
To clarify whether the interaction of syntenin with PIP2
is relevant for the biology of its peptide ligands, particu-
larly syndecan, we took advantage of a syntenin mutant
(syntenin PDZ1mut) that carries four point mutations in
the PDZ1 domain. When carrying these mutations, the
PDZ tandem of syntenin still binds with high affinity to
syndecan-2 (Grootjans et al., 2000), but fails to bind PIP2
(Zimmermann et al., 2002) (Figure 1C). When syndecan-2
was coexpressed with eGFP-syntenin PDZ1mut, both
proteins coaccumulated in a perinuclear compartment
(Figures 1D and 1E, arrows). This effect is illustrated in
MCF-7 cells, but it was reproduced in CHO-K1, COS-1,
HEK-293, HeLa, and HepG2 cells (data not shown).
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378Figure 1. Impairing Syntenin-PIP2 Binding Results in Perinuclear
Accumulation of Syndecan
(A) Domain structure of syntenin. (B and D–M) MCF-7 cells tran-
siently overexpressing syndecan-2, (B) alone or (D–M) in combina-
tion with eGFP-syntenin PDZ1mut. (C) Syntenin PDZ1mut contains
a mutant PDZ1 domain that abolishes PDZ-PIP2 binding (left), but
not syndecan binding (right). The coexpression of syndecan-2 with
syntenin PDZ1mut, whether (D and E) full-length, (H and I) trun-
cated for the C-terminal domain (C-Ter), or (J and K) truncated for
the N-terminal domain (N-Ter), results in perinuclear coaccumula-
tion of syndecan/syntenin (arrowheads). Such accumulation is not
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euch perinuclear accumulation of syndecan-2 was not
bserved when it was expressed alone (Figure 1B), i.e.,
n the absence of the syntenin mutant, or coexpressed
ith wild-type syntenin (Figures 2P–2R). Conversely,
yntenin PDZ1mut was nearly homogeneously distrib-
ted throughout the cytoplasm of MCF-7 cells when it
as coexpressed with a syndecan-2 that lacks its PDZ
inding domain (syndecan-2 C30) (Figures 1F and 1G).
o clarify whether domains other than the PDZ domains
ere playing a role in this perinuclear accumulation, we
nvestigated the effects of forms of syntenin PDZ1mut
dditionally missing the C-terminal (C-Ter; Figures 1H
nd 1I) or N-terminal domain (N-Ter; Figures 1J and
K). Also, these forms of syntenin coaccumulated with
yndecan-2 in a perinuclear compartment. We noticed
hat either of these deletions enhanced the perinuclear
ccumulation of syndecan-2, a feature that might be
xplained by the increased accessibility of the two PDZ
omains upon deletion of the N-Ter (Zimmermann et
l., 2001) or C-Ter domain (unpublished data). Similar
erinuclear redistributions were observed for all four
yndecans (data not shown). Restoring high affinity for
IP2, by fusing the syntenin PDZ1mut N-Ter to the PH
omain of PLCdelta (Raucher et al., 2000), rescued a
ormal distribution of syndecan-2 (Figures 1L and 1M).
e conclude that impairing the syntenin-PIP2 interac-
ion results in the intracellular accumulation of synde-
ans and that this effect is solely related to PDZ do-
ain interactions.
Syntenin Defective for PIP2 Binding Traps
yndecan in Recycling Endosomes
e characterized the compartment of accumulation by
onfocal microscopy, by using MCF-7 cells transiently
oexpressing syndecan-2 and eGFP-syntenin PDZ1mut
N-Ter (hereafter referred to as eGFP-syntenin-PIP2−),
nd we analyzed a minimum of 30 cells in every test.
arkers for the endoplasmic reticulum, such as cal-
exin (Figures 2A–2C), or for the cis or trans Golgi net-
ork, such as GM130 (Figures 2D–2F) or TGN46 (Fig-
res 2G–2I), never concentrated in the syndecan-2/
yntenin-PIP2− compartment. In contrast, transferrin re-
eptor (Figures 2J–2L) and EEA1 (Figures 2M–2O), two
arkers for endosomes, were colocalizing with synde-
an-2 and eGFP-syntenin-PIP2− in, respectively, 70%
nd 100% of the cells. EEA1 showed little if any colo-
alization with syndecan-2 when MCF-7 cells were
ransfected with eGFP (data not shown) or with eGFP-
yntenin-N-Ter containing wild-type PDZ domains
hereafter referred to as eGFP-syntenin) (Figures 2P–2R).
n such transfectants, intracellular syndecan-2 mainly
odistributed with markers of the secretory pathway,
nd not with markers of the endocytic pathway (databserved when syndecan-2 is (B) overexpressed alone, (L and M)
hen binding of the syntenin mutant to PIP2 is restored by fusion
o the PH domain of PLC, or (F and G) when the mutant syntenin
s expressed with a syndecan-2 that is defective for PDZ binding
ecause it lacks the last two C-terminal amino acids (syndecan-2
30). Syndecan-2 was detected by immunocytochemistry (left pan-
ls), and syntenin was detected by eGFP fluorescence (right pan-
ls), by using wide-field microscopy. The scale bar is 100 m.
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379Figure 2. Syntenin Defective for PIP2 Binding and Syndecan Coac-
cumulate in an Endocytic Compartment
(A–V) Confocal immunofluorescence micrographs of MCF-7 cells
transiently expressing (A–R) syndecan-2, together with an eGFP-
syntenin-N-ter that is (A–O) defective (syntenin-PIP2−) or (P–R)
competent (syntenin) for PIP2 binding. (A–R) Syndecan-2 (left pan-
els) and various endogenous markers (as indicated, right panels)not shown). Colocalizations with endocytic markers were
similarly observed for full-length or C-terminally trun-
cated forms of syntenin that were defective for PIP2
binding (data not shown), indicating that endosomal
redistribution is solely related to PDZ domain interac-
tions. To confirm the endocytic nature of the compart-
ment, we incubated living MCF-7 cells, overexpressing
syndecan-1 and eGFP-syntenin-PIP2−, with monoclonal
antibodies recognizing the extracellular domain of the
transfected syndecan. Knowing that monovalent and
bivalent anti-syndecan antibodies are internalized in a
syndecan-dependent manner and with comparable ki-
netics (see below, and compare Figure 4B and Figure
4C), we presumed that such antibodies were reliable
tracers of syndecan endocytosis. After 20 min of incu-
bation, the anti-syndecan-1 antibody started accumu-
lating in the neighborhood of the perinuclear compart-
ment labeled by syntenin-PIP2− (Figure 2T, compare
upper and middle panel). After 4 hr, the localization of
intracellular anti-syndecan-1 nearly coincided with that
of the eGFP-syntenin-PIP2− compartment (Figure 2V).
Time-lapse video microscopy, following the internaliza-
tion of fluorescent anti-syndecan-1 antibodies, indi-
cated that most anti-syndecan-loaded vesicles were
rapidly moving toward the eGFP-syntenin-PIP2− com-
partment, the vesicles tethering to and ultimately fusing
with this compartment (Movie S1; see the Supplemen-
tal Data available with this article online). This was not
limited to transfected syndecans, as perinuclear coac-
cumulations of eGFP-syntenin-PIP2− and internalized
antibody could be observed in cultured cells express-
ing only eGFP-syntenin-PIP2−, provided these cells ex-
pressed high amounts of cognate endogenous synde-
can (data not shown). We conclude that impairing the
syntenin-PIP2 interaction results in the perinuclear en-
dosomal accumulation of internalized syndecan and
that neither N-Ter nor C-Ter domains of syntenin are
required for this accumulation.
To further define in what endosomal compartment
syndecan and syntenin-PIP2− were coaccumulating,
these proteins were coexpressed with tagged small
GTPases that are involved in different steps of the en-
dosomal traffic. Neither Rab5, an early endosomal
marker (Figures 3A–3C), nor Rab4, an endosomal
marker for the rapid recycling pathway (Figures 3D–3F),
nor Rab7, a late endosomal marker (Figures 3G–3I),
were concentrated in the syndecan/syntenin-PIP2−
compartment. On the contrary, small GTPases impli-were detected by immunocytochemistry; syntenin was identified
by eGFP fluorescence (middle panels). Note that endocytic mark-
ers, (J–L) transferrin receptor and (M–O) EEA1, colocalize with the
syndecan/syntenin perinuclear accumulations. This is not the case
for the endoplasmic reticulum marker, (A–C) calnexin, and for the
Golgi markers (D–F) GM130 and (G–I) TGN46. In the experiment
shown in the last three rows of (S)–(V), living cells overexpressing
syndecan-1 and eGFP-syntenin-PIP2− were (T–V) incubated or (S)
not incubated with monoclonal anti-syndecan-1 IgG1 (BB4) for (T)
20 min, (U) 2 hr, or (V) 4 hr before fixation. Primary antibodies were
detected by fluorescent secondary antibodies (upper row, red in
lower row), and syntenin was detected by eGFP fluorescence (mid-
dle row, green in lower row). Note the progressive colocalization of
the anti-syndecan-1 antibodies with the eGFP-syntenin-PIP2− sig-
nal (arrowheads). The scale bars are 10 m.
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380Figure 3. Syndecan and a Syntenin Defective for PIP2 Binding
Coaccumulate with Recycling Endosome Markers; Syndecan Re-
cycling
(A–O) (A–L) Wide-field or (M–O) confocal immunofluorescence
micrographs of MCF-7 cells transiently expressing syndecan-2, to-
gether with eYFP, eCFP, or eGFP fusions to syntenin-PIP2− and vari-
ous tagged small GTPases, as indicated. Syndecan-2 (left panels)
and (O) Arf6 small GTPase were detected by immunocytochemis-
try; syntenin-PIP2− (middle panels) and the different Rab GTPases
(right panels) were detected by the eYFP, eCFP, or eGFP fluores-
cence as indicated. Note that neither (C) Rab5, a marker of early
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cated in slow recycling, namely, Rab11 (Ullrich et al.,
996) and Arf6 (D’Souza-Schorey et al., 1995; Peters
t al., 1995; Radhakrishna and Donaldson, 1997), did
oncentrate in this compartment (Figures 3J–3O) in, re-
pectively, 50% and 100% of the cells. The patterns of
rf6 and Rab11 distribution were grossly altered in the
yndecan/syntenin-PIP2− cells, as were the distribu-
ions of transferrin receptor (see Figure 2L) and EEA1
see Figure 2O). This suggests that the juxtanuclear en-
ocytic recycling compartment is engorged by accu-
ulating syndecan/syntenin-PIP2− complexes. Never-
heless, fluorescence video microscopy showed that
ransferrin could still enter and exit endosomes that
ere loaded with syndecan/syntenin-PIP2−, demon-
trating that this compartment is still functional for re-
ycling. Moreover, fluorescence flow cytometry revealed
imilar rates of transferrin recycling in syndecan/syn-
enin-PIP2− and control cells (Figure S1). Finally, E-cad-
erin, a molecule known to follow endocytic recycling
outes (Le et al., 1999; Paterson et al., 2003), was not
locked in the syndecan/syntenin-PIP2− compartment
Figure S2). All together, these data indicated that syn-
ecan/syntenin-PIP2− expression is not inducing a gen-
ral block of the endocytic recycling pathway. Rather,
hey suggested that syntenin-PIP2− may specifically
isturb Arf6-dependent trafficking processes. Since the
rf6 recycling compartment arises from the juxta-
uclear endocytic recycling compartment (Weigert et
l., 2004), this would explain the partial codistribution
f syndecan/syntenin-PIP2− with transferrin receptor
nd Rab11. Moreover, the Arf6 endosomes acquire
EA1, especially in the juxtanuclear area (Naslavsky et
l., 2003), which is consistent with the presence of this
arker in the syndecan/syntenin-PIP2− compartment.
inally, this compartment also contains CD59 and
HCI (Figure S2), molecules recycling by Arf6 routes
Naslavsky et al., 2004; Radhakrishna and Donaldson,
997).
The above observations further implied that synde-
ans might recycle, which was, to our knowledge, thus
ar not suspected. We tested for recycling of endoge-
ous syndecan-1 in MCF-7 cells, which express detect-
ble amounts of this syndecan after 2 days of culture,
y using biotinylation experiments. Under “constitu-
ive” conditions, i.e., in the continuous presence of se-
um (Figure 3P, upper part) or in the continuous ab-
ence of serum (data not shown) during the entire
eriod of internalization and chase, we were not ablendosomes, nor (F) Rab4, a marker for fast recycling endosomes,
or (I) Rab7, a marker for late endosomes colocalize in the synde-
an/syntenin-PIP2− perinuclear accumulations, while two recycling
ndosome markers, (L) Rab11 and (O) Arf6, do colocalize. The
cale bar is 10 m.
P) Cell surface proteins of MCF-7 cells were biotinylated and al-
owed to internalize for 2 hr in the presence or absence of serum.
fter removal of cell-surface biotin, serum-exposed cells (test for
constitutive” recycling) and serum-starved cells (test for “stim-
lated” recycling) were incubated in the presence of serum for the
ndicated times. Two sets of samples were prepared in parallel: one
o determine the intracellular and surface-recycled pools, and an-
ther to determine the total amount of biotinylated syndecan-1.
yndecan-1 was detected by Western blotting. Note that synde-
an-1 recycling is apparent under stimulatory conditions.
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381to detect syndecan recycling. Intracellular and total bi-
otinylated syndecan rapidly disappeared from the cells,
and little was detectable at the cell surface. Yet, adding
serum to cells that had been starved during internaliza-
tion, a condition that stimulates the Arf6 recycling path-
way (Brown et al., 2001), induced syndecan recycling.
Under such a “stimulatory” condition, biotinylated syn-
decan-1 at the cell surface increased with time, with a
concomitant decrease of biotinylated intracellular syn-
decan-1, and the total pool of biotinylated syndecan-1
remained near constant. These findings are clear indic-
ations of recycling (Figure 3P, lower part).
Given that syndecans recycle upon stimulation, two
reasons could account for the accumulation of synde-
can together with syntenin-PIP2− in recycling endo-
somes. Either the residence time of syndecan/syntenin
complexes at the plasma membrane is decreased, so
that they reach the recycling compartment too rapidly
to be redirected efficiently, or their exit from recycling
endosomes is slowed down. Several observations ar-
gued against the first hypothesis. First, nascent synde-
can endosomes (traced in anti-syndecan antibody
uptake experiments) were never decorated with eGFP-
syntenin-PIP2− or eGFP-syntenin, arguing against a role
for this interaction in the internalization process from
the plasma membrane itself (data not shown). Second,
the rate of syndecan internalization, followed in biotin-
ylation experiments, upon stimulation with serum or un-
der constitutive conditions was similar in eGFP-syn-
tenin-PIP2− and eGFP-syntenin transfectants (Figure
4A). Third, the absence of the syntenin binding site in
syndecan did not influence the rate of endocytosis of
anti-syndecan Fab# antibodies or IgG (Figures 4B and
4C). Therefore, we conclude that impairing the syn-
tenin-PIP2 interaction severely retains syndecan/syn-
tenin complexes in recycling endosomes, which affects
the morphology of this compartment.
Syntenin Supports Syndecan’s Return to the Plasma
Membrane, Pending Arf6 Activation and Subsequent
PIP2 Synthesis on Recycling Endosomes
Type I phosphatidylinositol 4-phosphate 5-kinase (PIPK),
the main enzyme responsible for PIP2 production, is a
downstream effector of the small GTPase Arf6 (Honda
et al., 1999). PIPK activity and PIP2 turnover, controlled
by cycles of Arf6 activation and inactivation, are critical
for trafficking through this endosomal recycling path-
way, back to the plasma membrane (Brown et al., 2001).
The current model for Arf6-mediated vesicular traffick-
ing (Figure 5A) proposes that, following internalization
from the plasma membrane, GTP hydrolysis on Arf6 is
needed, generating Arf6-GDP that decorates the so-
called Arf6 recycling endosomes and allowing PIP2
levels to be lowered. Indeed, the expression of the
GTPase-defective, dominant-positive Arf6 Q67L mu-
tant (mimicking Arf6-GTP) induces the accumulation of
endosomes decorated with PIP2 that tether to and fuse
with one another without proceeding further. Studies in
cells transfected with Arf6 Q67L indicated that synde-
cans do not require interaction with syntenin to reach
such endosomes (data not shown), which is consistent
with the above-described evidence that syntenin has
no role in the internalization of syndecan. The modelFigure 4. Syntenin Defective for PIP2 Binding and the Syntenin
Binding Site of Syndecan Do Not Affect Syndecan Internalization
(A) Internalization of surface-biotinylated syndecan-2 in MCF-7
cells transiently expressing wild-type syndecan-2 together with an
eGFP fusion to a syntenin that is either competent (upper panel) or
defective (lower panel) for PIP2 binding. Lane T shows the total
amount of biotinylated syndecan-2 before internalization. After the
indicated time of internalization at 37°C, surface biotin was re-
moved, intracellular biotinylated proteins were collected on strep-
tavidin beads, and heparitinase-treated syndecan was detected by
Western blotting. Blots illustrate results obtained with cells kept in
the absence of serum. Similar results were obtained with cells kept
under serum or with starved cells stimulated with serum during the
internalization. Note that the kinetics of internalization are similar
in the presence of either form of syntenin.
(B and C) CHO-K1 stable clones expressing wild-type syndecan-2
or a syndecan-2 defective for PDZ binding (C30 or EAYA) were al-
lowed to internalize (B) 125I-Fab# fragments of mouse monoclonal
IgG antibodies specific for syndecan-2 or the (C) corresponding
125I-IgG for the indicated times at 37°C. Endocytosis is expressed
as the ratio of trypsin-resistant (R) over trypsin-sensitive (S) counts.
Values are means of three dishes and are representative of at least
four experiments. Error bars indicate standard deviations from the
mean. Note that the kinetics of internalization are similar for all
syndecan-2 forms.further proposes that fusion of Arf6 recycling endo-
somes back to the plasma membrane implies Arf6 (re)-
activation, PIPK recruitment, and a local increase of
PIP . Arf6 T27N (mimicking Arf6-GDP) blocks the return2
Developmental Cell
382Figure 5. Syndecan Recycling to the Cell Surface Depends on Syntenin, PIP2, and Arf6
(A) Current model for Arf6-regulated membrane traffic and its link with PIP2 turnover (for an explanation, see the text).
(B–E) Confocal immunofluorescence micrographs of (B and C) MCF-7 cells or (D and E) HepG2 cells transiently expressing dominant-negative
HA- or eGFP-tagged Arf6 T27N (which blocks Arf6-dependent recycling to the plasma membrane). Endogenous (endo) syntenin, syndecan-1, and
HA-Arf6 T27N were detected by indirect immunofluorescence; eGFP-Arf6 T27N was detected by eGFP fluorescence. Merged images, on the
right, show syntenin or syndecan-1 in green, and Arf6 T27N in red. Note the intracellular accumulations of syntenin and syndecan-1 (arrowheads).
The bars are 10 m.
(F and G) MCF7 cells transiently expressed syndecan-2 together with eGFP (for control), or an eGFP fusion to syntenin, either competent or
defective for PIP2 binding, and wild-type Arf6 or its T27N mutant (as indicated). Cells were biotinylated and allowed to internalize for 2 hr in
PDZ-PIP2 Interaction Supports Syndecan Recycling
383of Arf6 recycling endosomes to the plasma membrane
(Radhakrishna and Donaldson, 1997). Because of these
characteristics of the Arf6 recycling pathway, we sur-
mised that syndecan fails to exit from Arf6 recycling
endosomes when it is linked to a syntenin that is unable
to bind PIP2.
We first investigated the effect of dominant-negative
Arf6 (Arf6 T27N) on the distribution of endogenous syn-
tenin and syndecan. Consistent with a connection of
syntenin with the Arf6 recycling pathway in MCF-7
cells, expression of Arf6 T27N induced accumulation of
endogenous syntenin in the perinuclear region (Figures
5B and 5C). A similar effect was observed when a domi-
nant-negative PIPK− was expressed (data not shown).
The expression of Arf6 T27N also resulted in intracellu-
lar retention of endogenous syndecan. This was more
easily observed in HepG2 cells, which express high
levels of syndecan-1. When these cells were incubated
for 4 hr with monoclonal antibodies directed against the
syndecan-1 extracellular domain and then fixed, there
was substantial codistribution of the syndecan-1 signal
with the Arf6 T27N compartment (Figures 5D and 5E,
arrowheads).
To further investigate the role of syntenin in syndecan
recycling, we performed biotinylation experiments on
MCF-7 cells overexpressing syndecan-2. The (serum-
stimulated) recycling of syndecan-2 was accelerated
by transfection with eGFP-wild-type syntenin, suggest-
ing that syntenin is a rate-limiting factor in this recycling
(Figure 5F). Cotransfection of wild-type syntenin with
wild-type Arf6 did not further affect syndecan-2 recycl-
ing, but either replacing Arf6 by Arf6 T27N or replacing
wild-type syntenin by a syntenin that is defective for
PIP2 binding slowed down syndecan-2 recycling (Fig-
ure 5G). These kinetic studies were complemented by
confocal microscopy, addressing steady-state distribu-
tions. Whereas in control conditions syndecan-2 and
eGFP-syntenin mainly colocalized at the plasma mem-
brane (Figures 5H and 5I), Arf6 T27N overexpression
induced accumulation of the two proteins in perinuclear
Arf6 recycling endosomes (Figures 5J–5L). Expressing
a PIPK lacking half of its kinase domain and acting as
a dominant negative (Myc-PIPK−) (Galiano et al., 2002)
also caused intracellular coaccumulation of syndecan
and syntenin (Figures 5M–5O). Since the Arf6 recycling
compartment is characterized by a low level of PIP2, we
also tested for the presence of PIP2 in the syndecan/
syntenin-PIP − endosomes. Lack of labeling by an2
the absence of serum. After removal of cell surface biotin, cells were incubated in the presence of serum for the indicated times. Two sets of
samples were prepared in parallel: one to determine internalized (I), the other to determine total (T) biotinylated syndecan. Syndecan-2 was
detected by Western blotting. Recycled syndecan was calculated by subtracting internalized from total biotinylated syndecan and was
expressed as a percentage of the total biotinylated syndecan present at time zero. Similar results were obtained in three independent
experiments. Note that recycling is promoted by (F) syntenin overexpression and slowed down by (G) dominant-negative Arf6 T27N or
syntenin defective for PIP2 binding (syntenin-PIP2−).
(H–R) (H–O) Confocal or (P–R) wide-field immunofluorescence micrographs of MCF-7 cells. (H–O) Cells transiently expressed syndecan-2 and
an eGFP fusion to syntenin competent for (H and I) PIP2 binding, together with either (J–L) HA-tagged dominant-negative Arf6 T27N, or (M–O) Myc-
tagged dominant-negative type I phosphatidylinostol 4-phosphate 5-kinase (Myc-PIPK−). Syndecan-2, Arf6 T27N, and PIPK− were detected by
immunocytochemistry, and syntenin was detected by eGFP fluorescence. Merged images, on the right, show syndecan in red, syntenin in
green, and Arf6 T27N or PIPK− in blue. Note that in (H) and (I) syndecan-2 and syntenin codistribute at the plasma membrane, but that in the
presence of dominant-negative Arf6, in (J)–(L), or PIPK−, in (M)–(O), they coaccumulate in perinuclear compartments. (P–R) Cells transiently
expressed syndecan-2 (revealed by immunocytochemistry), together with an eYFP fusion to syntenin-PIP2− and eCFP fused to a PIP2-probe
(PH-PLC) that were detected by intrinsic fluorescence. Note that syndecan/syntenin-PIP2− endosomes are not enriched in PIP2, as expected
for Arf6 perinuclear recycling endosomes. The scale bars are 10 m.
spreading area of these transfectants was reduced byeGFP that is fused to the PH domain of PLCdelta indi-
cated that this compartment is indeed poor in PIP2 (Fig-
ures 5P–5R).
We conclude that syndecan recycling to the plasma
membrane depends on syntenin and that syntenin-
mediated recycling relies on Arf6 and on the ability of
syntenin to interact with PIP2.
Syntenin-Dependent Recycling Controls
Syndecan-Dependent Processes
Syndecan binds and controls the activity of several ad-
hesion and signaling molecules, via its HS chains.
Therefore, we wondered whether syndecan directs HS
ligands through the syntenin recycling pathway. FGF re-
ceptor, a component of a signaling system controlled
by HS (Rapraeger et al., 1991), accumulated in synde-
can/syntenin-PIP2− endosomes (Figures 6A–6C). Since
the interaction of FGF receptor with HS depends on
FGF (Schlessinger et al., 2000), we further tested
whether this ligand is required for FGF receptor accu-
mulation in syndecan/syntenin-PIP2− endosomes. When
cells were serum starved for 24 hr, FGF receptor no
longer concentrated in syndecan/syntenin-PIP2− endo-
somes (Figures 6D–6F), but started accumulating again
in this compartment within 30 min after FGF2 addition
(Figures 6G–6I). Such accumulation was not observed
when cells expressed a syndecan that lacked HS (Fig-
ures 6J–6L). These observations imply that FGF-FGF
receptor complexes, and potentially several other HS
ligands on syndecan, might traffic along the syntenin
recycling pathway in a syntenin-PIP2-dependent manner.
Arf6 activation and subsequent membrane recycling
are required for cell spreading (Song et al., 1998). Inter-
estingly, we noticed that cells accumulating syndecan-
2/syntenin-PIP2− tended to be less spread than un-
transfected cells (data not shown) or cells expressing
only syndecan-2 (Figure 6M). Yet, cell spreading was
preserved when syntenin-PIP2− was coexpressed with
a syndecan-2 that lacks HS, (Figure 6M), suggesting
that the effect on spreading results from the trapping
of syndecan-cargo involved in cell adhesion/signaling
rather than from the trapping of syndecan-2 itself. Thus,
syntenin, syndecan, and syndecan-cargo might play an
important role in the control of cell spreading by Arf6.
Consistent with this idea, the sole expression of synde-
cans that lacked a PDZ binding domain (as C30 or
EAYA mutants) also inhibited cell spreading. The mean
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cesses
(A–L) Confocal micrographs of MCF-7 cells transiently expressing
(A–I) syndecan-2 or a (J–L) syndecan-2 missing its HS attachment
domain (syndecan-2 HS), together with an eGFP fusion to syn-
tenin-PIP2− and the FGF receptor tagged with HA. Cells were cul-
tured (A–C) in the presence of serum or were (D–L) serum starved
for 24 hr. (G–L) Cells were treated with 10 ng/ml FGF2 (bFGF) for
30 min. Syndecan-2 and FGF receptor were detected by immuno-
cytochemistry; syntenin-PIP2− was detected by eGFP fluores-
cence. Merged images, on the right, show syndecan in red, syn-
tenin in green, and the FGF receptor in blue. Note that the
accumulation of FGF receptor with syndecan/syntenin-PIP2− de-
pends on serum or FGF2, and on HS. The scale bars are 10 m.
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dalf compared to cells transfected with wild-type syn-
ecan (Figure 6M). A syndecan-2 C30 mutant lacking
S chains (syndecan-2 C30  HS), in contrast, failed to
nhibit cell spreading. We interpret these data as indi-
ating that syndecans that lack a PDZ binding site,
nce internalized, fail to recycle in a syntenin-Arf6-
ependent manner and become trapped within the cell
ogether with important cargo that is essential for the
preading process. In support of these concepts, we
ound β1-integrins to accumulate in the syndecan/syn-
enin-PIP2− compartment and the internalized synde-
an-2 C30 mutant to be more rapidly degraded than
ild-type syndecan-2 (Figure S2). Furthermore, we
ound that syntenin knockdown by siRNA treatment in-
uced cell rounding and resulted in cell detachment
Figure 6N). We conclude that syndecan, and several
S binding molecules that represent syndecan cargo,
raffic along the syntenin recycling pathway and influ-
nce cell spreading.
iscussion
aken together, our data show that plasma membrane
yndecan enters the endosomal compartment indepen-
ently of PDZ and syntenin interactions (Figure 7A). At
ome stage between early (EE) and recycling (RE) en-
osomes, wild-type syndecan interacts with syntenin
Figure 7B). The recycling of syndecan/syntenin endo-
omes to the plasma membrane relies on the ability of
yntenin to interact with PIP2 (Figure 7C). The produc-
ion of PIP2 on these endosomes depends on the acti-
ation of Arf6 GTPase, which in turn can recruit PIPK.
ominant-negative Arf6 (Arf6 T27N), dominant-nega-
ive PIPK, and a syntenin defective for PIP2 binding
Figure 7D) all cause syndecan/syntenin coaccumula-
ion in recycling endosomes, which ultimately results in
he engorgement of the perinuclear recycling compart-
ent. Importantly, multiple adhesion and signaling
olecules that bind to the HS chains of the syndecans
re likely to be trapped in these endosomes. We pro-
ose that a consequent reduction in their cell surface
vailability and activity explains the observed inhibition
f cell spreading. Blocking syndecan recycling by in-
ibiting its interaction with syntenin/PDZ domains (Fig-
re 7E) has a similar effect on cell spreading as doesM) Effects on cell spreading were analyzed in MCF-7 cells after
ransient overexpression of either: syndecan-2; syndecan-2 to-
ether with eGFP-syntenin-PIP2−; a syndecan-2 mutant lacking HS
hains ( HS) together with eGFP-syntenin-PIP2−; a mutant synde-
an-2 with impaired PDZ interaction (C30, EAYA); or a syndecan-2
utant lacking both HS chains and the PDZ binding domain (C30
HS). Values indicate the mean cell spreading area calculated from
0 cells taken at random. Error bars indicate standard deviations
rom the mean.
N) Upper part: syntenin levels in MCF-7 (human) cells or NMuMg
mouse) cells, after one (first hit) or two (second hit) rounds of trans-
ection with siRNA duplexes for human (h) or mouse (m) syntenin,
ere evaluated by Western blotting. Note the significant reduction
f the signal after two hits, and the species specificity of the ef-
ects. Lower part: differential interference contrast micrographs of
CF-7 cells transfected twice with human (h) or mouse (m) siRNA
s indicated. Note that cellular knockout of syntenin induces cell
etachment. The scale bar is 100 m.
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Syndecan Recycling and Cell Spreading
EE, early endosome; RE, recycling endosome.
See the Discussion for explanation.loss of syntenin function and may orient internalized
syndecan to lysosomes for degradation, rather than to
recycling compartments. Syndecans that cannot in-
teract with syntenin, but carry no HS, are not able to
trap HS-cargo and consequently do not inhibit cell
spreading.
It is becoming increasingly clear that PDZ binding
motifs in plasma membrane proteins, and PDZ proteins
interacting with these motifs, are strongly involved in
the regulation of receptor densities at cell surfaces.
PDZ binding, by syndecans in particular, has been im-
plicated in receptor/syndecan trafficking in the early se-
cretory pathway (Fernandez-Larrea et al., 1999). While
syntenin or another PDZ protein may mediate this
transport, it is clearly not at this step of receptor/synde-
can trafficking that the interaction of the syntenin PDZ
domains with PIP2 plays a role, as no Golgi markers
could be identified in the intracellular compartment
where syntenin-PIP2− impairs syndecan trafficking.
PDZ binding motifs have also been identified as cell
surface retention signals, as in some instances loss of
the motif from the receptor (i.e., GABA transporter)
causes increased receptor endocytosis and overex-
pression of cognate PDZ proteins (i.e., NHERF) reduces
receptor (i.e., EGFR) internalization (Lazar et al., 2004;
Perego et al., 1999). However, abrogation of the PDZ
binding motif in syndecans does not affect their rate of
endocytosis. Likewise, the syntenin-PIP2− mutant does
not accelerate the internalization of syndecan and
rather appears to associate with syndecans at a postin-
ternalization step. Thus, abrogating syntenin-PIP2 bind-
ing does not primarily affect the cell surface retention
of syndecans. In contrast, our data are entirely consis-
tent with the increasing evidence that PDZ proteins reg-
ulate endocytic recycling of membrane proteins. The
PDZ protein NHERF/EBP50 regulates the recycling of
β-adrenergic (Cao et al., 1999) and κ-opioid (Li et al.,
2002) receptors and possibly also that of the cystic fi-
brosis transmembrane conductance regulator (Swia-
tecka-Urban et al., 2002). In addition, conferring a PDZ
binding motif to the δ-opioid receptor, which is normally
endocytosed and degraded, orients this receptor to therecycling pathway (Gage et al., 2001). Our data extend
this evidence, revealing a role for syntenin in syndecan
recycling. More importantly, to our knowledge, they
also provide the first indication for a mechanistic link
to phosphoinositide turnover as regulated by the small
GTPase Arf6.
Both PDZ domains of syntenin can bind to either syn-
decan or PIP2, but syndecan exhibits higher affinity for
PDZ2 than for PDZ1, while, inversely, PIP2 has higher
affinity for PDZ1 than for PDZ2. Yet, individual PDZ do-
main interactions are weak, and a stable high-affinity
interaction requires a dual docking of the PDZ domains
to peptides, to PIP2, or a combination thereof (Zimmer-
mann et al., 2002). Our data therefore suggest a
scheme whereby syntenin adapts to the clustered cyto-
plasmic domains of internalized syndecans, and in
which it has no role in endocytosis itself. Syntenin is
dually docked to these internalized syndecans, as the
PIP2 levels in the compartment are low. PIP2 synthesis
on these membranes, initiated by Arf6 activation, al-
lows for the exchange of PIP2 for the syndecan that is
docked into the PDZ1 domain of syntenin, a require-
ment for syntenin bringing the syndecan that is still
docked into its PDZ2 domain back to the cell surface.
Alternatively, high levels of PIP2 may completely re-
place the syndecans, liberating them from syntenin and
allowing their return to the cell surface. This alternative
scenario would primarily consider syntenin as an intra-
cellular retention machine, with a role similar to that of
the PDZ protein GRIP/ABP in AMPA receptor recycling,
stabilizing an intracellular pool of receptors that have
been internalized and inhibiting their return to the
plasma membrane (Braithwaite et al., 2002). However,
a retention function, turned off by a PIP2 switch, seems
inconsistent with the evidence that high levels of syn-
tenin favor syndecan recycling, unless syntenin would
also act to introduce/sort internalized syndecans into
the compartment where the switch can operate and re-
cycling can be initiated. The machinery that drives the
return of syndecan to the plasma membrane remains
unknown. This machinery probably does not require
any direct association with a syndecan/syntenin/PIP2
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syntenin, reduced to the PDZ tandem, will block synde-
can trafficking, which is not what is observed. There-
fore, it seems more likely that this machinery involves
Arf6 effectors (Prigent et al., 2003) and the lateral asso-
ciation of syndecans or syndecan/PIP2 complexes in
the plane of the endosomal membranes.
Along with syndecan, ligands for the HS chains of
syndecan and cognate receptors are trapped in the en-
dosomes where syndecans are arrested when syntenin
cannot switch to PIP2. Thus, transfer of syntenin to PIP2
may be needed for syndecan-based complexes to
reach distal compartments where ligand-receptor disso-
ciation normally occurs before syndecan, and possibly
the receptors it assists, recycles to the cell surface.
FGF receptors and integrins belong to the ever-growing
category of “syndecan-assisted” receptors. Whereas
internalized FGF receptors are thought to be mostly
downregulated in lysosomes, β1-integrins involved in
cell adhesion, spreading, and motility also recycle by
the Arf6 pathway in a stimulus-dependent way (Po-
welka et al., 2004). Consistently, we detected β1-inte-
grin in the syndecan-2/syntenin-PIP2− compartment in
MCF-7 cells. The present data strongly suggest that re-
cycling-defective syndecans negatively interfere with
cell spreading because of “dominant-negative” effects
on syndecan-cargo. This implies that syndecans may
also assist molecules like integrins in postinternaliza-
tion steps, including their cell surface recycling. Arf6
controls part of the complex interplay between signal
transduction, membrane traffic, and the cytoskeleton
(Donaldson, 2003). Also, syndecan contributions to the
control of the cytoskeleton and signal transduction are
well documented (Couchman, 2003). Fundamental pro-
cesses that depend on the ability of the cells to spread,
like wound healing, cell adhesion and migration, and
cell polarization are dependent on both Arf6 and synde-
can. The link made here between syndecan, HS-ligands,
and Arf6-dependent membrane recycling conceivably
identifies one piece of the molecular framework by
which Arf6 and syndecan control cell behavior. Addi-
tionally, it establishes the functional relevance of syn-
tenin and PDZ domain-PIP2 interactions.
Experimental Procedures
Cell Culture and Transient Transfections
All cell lines were obtained from the American Type Culture Collec-
tion and were routinely grown in DMEM/F12 medium (Life Technol-
ogies) supplemented with 10% fetal bovine serum (Hyclone), which
was replaced by 0.1% BSA (Sigma) for serum starvation. For micro-
scopic analyses, cells were plated on noncoated chamber slides
(Nalge Nunc), transfected after 7 hr by using FuGENE 6 (Roche)
with the appropriated expression vectors and were fixed 24 hr later.
For FGF experiments, MCF-7 cells were transfected in serum-free
DMEM/F12 medium and 24 hr later were incubated in serum-free
DMEM/F12 medium containing 10 ng/ml FGF2 (Roche). For bio-
chemical experiments, cells were plated in culture dishes, trans-
fected as described above, and analyzed 36 hr after transfection.
For syntenin silencing experiments, freshly plated human (MCF-7)
or mouse (NMuMg) cells were transfected with siRNA duplexes by
using Lipofectamine 2000 (Invitrogen).
Immunostaining
Cells were fixed with 4% paraformaldehyde for 20 min and permea-
bilized for 10 min with 0.1% Triton X-100 in PBS. Cells were incu-
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tated with primary antibodies at room temperature for 1 hr and
or 30 min with appropriate Alexa-conjugated secondary antibodies
Molecular Probes). When indicated, primary antibodies were
dded to living cells at 37°C, prior to fixation.
iochemical Analysis of Syndecan Recycling
CF-7 cells were biotinylated (2 × 20 min) with reducible sulfo-
HS-SS-biotin (Pierce) at 4°C. After internalization, cell surface
iotin was removed by treatment (2 × 20 min) at 4°C with sodium
-mercaptoethanesulfonate (MesNa, Sigma) and cells were al-
owed to resume their membrane trafficking at 37°C for the indi-
ated times. To determine intracellular and recycling pools, a first
et of cells was incubated with streptavidin (Sigma) before cell lysis
o capture biotinylated proteins that had recycled to the cell sur-
ace. Biotin binding sites remaining free on cell bound streptavidin
ere then blocked by adding excess biotin. After cell lysis, strep-
avidin complexes were immunoprecipitated with an anti-streptavi-
in antibody (Abcam). Biotinylated proteins remaining in the lysate
not complexed to streptavidin and thus corresponding to the intra-
ellular pool) were captured by using streptavidin beads (Pierce).
otal biotinylated proteins were isolated from a second set of cells
repared in parallel by adding streptavidin beads directly to the
ell lysate. The different pools were analyzed by Western blotting,
fter heparitinase digestion, by using BB4 anti-syndecan-1 anti-
ody. MCF-7 cells that transiently overexpressed syndecan-2 were
iotinylated, allowed to internalize in the absence of serum,
tripped of cell surface biotin, as described above, and then further
ncubated in the presence of serum for the indicated times. At each
ime point, total biotinylated proteins were isolated from one set of
ishes by adding streptavidin beads directly to the cell lysate. In
arallel dishes, biotin was stripped from the plasma membrane
roteins by MesNa reduction. Streptavidin beads were then added
o the lysate to capture the internalized biotinylated proteins. After
eparitinase digestion, total and internalized biotinylated synde-
an-2 was detected in Western blotting by using rabbit polyclonal
ntibodies directed against the extracellular domain. The chemilu-
inescence signals were quantified by using a KODAK Image Station
40CF with Kodak 1D Image Analysis Software (Eastman Kodak
ompany). The differences between total and intracellular pools of
yndecan represent cell surface pools, since shedding of biotin-
lated syndecan was undetectable over the same time periods
data not shown).
iochemical Analysis of Syndecan Endocytosis
fter surface biotinylation (as for recycling), cells were incubated at
7°C for the indicated times. The internalization of the cell surface
roteins was stopped by a cold PBS wash, and remaining cell sur-
ace biotin was removed by MesNa treatment (see above). Internal-
zed biotinylated proteins present in cell lysates were captured on
treptavidin beads. After heparitinase digestion (Seikagaku Corpo-
ation), internalized syndecan-2 was detected by Western blotting
ith rabbit polyclonal antibodies directed against the extracellular
omain. Fab# fragments of mouse monoclonal 10H4 were pro-
uced by digestion of IgG with pepsin (Sigma). The disulfide bridge
etween the truncated heavy chains was reduced by incubation in
TT. The complete reduction into Fab# was verified by SDS-PAGE.
hole IgG or Fab# fragments were labeled by the chloramine T
ethod to a specific activity of w5000 cpm/ng, stored at 4°C, and
sed within 2 weeks. To measure endocytic uptake, cells were
ransferred to 4°C, then incubated in fresh medium containing 1%
CS together with 200 ng/ml 125I-IgG or 125I-Fab# fragments, for 1
r on ice. After rapid washes, cells were further incubated at 37°C
or the indicated intervals. The cells were washed and surface di-
ested with 0.2% trypsin for 1 hr at 4°C. Trypsin-released radioac-
ivity was taken as a measure of cell surface bound antibody. Cells
ere further rinsed, lysed in 0.01% Triton X-100, and analyzed for
rotein and radioactivity. This value was taken as a measure of
ntracellular tracer. The integrity of 125I-Fab# was verified. Values
ere normalized to the cell protein content and expressed as a
atio of intracellular (trypsin-resistant)/surface bound (trypsin-sen-
itive) counts.
dditional Experimental Protocols
or eukaryotic expression vectors, syndecan-2 stable transfec-
ants, primary antibodies, microscopic analysis, siRNA duplexes,
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387and silencing experiments, see the Supplemental Experimental
Procedures.
Supplemental Data
Supplemental data including Supplemental Experimental Pro-
cedures, two figures, and one movie are available at http://www.
developmentalcell.com/cgi/content/full/9/3/377/DC1/.
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